InventHelp Inventor Develops Improved Tool for Law Enforcement & Security Officers (LGI-2998)
- S&P 500, Dow climb for third day and close at records
- Tesla (TSLA) China Numbers 'Robust' - Wedbush
- Apple (AAPL) Shares Seen as 'Attractive' as Recent Checks Show Continuously Strong Demand - Citi
- Amazon.com warehouse workers vote to reject forming union in Alabama
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
PITTSBURGH, March 19, 2021 /PRNewswire/ -- "I'm a TSA public safety officer and I wanted to create a safe and efficient tool to assist when searching bags for contraband items," said an inventor, from Williston Park, N.Y., "so I invented the TACTICAL FLASHLIGHT. My design provides added illumination and safety for officers."
The invention provides an improved security/law enforcement product. In doing so, it offers a non-hand contact method of conducting bag and vehicle searches. It also increases illumination and it provides added protection and peace of mind. The invention features a durable design that is convenient and easy to use so it is ideal for law enforcement and security officers. Additionally, it is producible in design variations.
The original design was submitted to the Long Island sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-LGI-2998, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/inventhelp-inventor-develops-improved-tool-for-law-enforcement--security-officers-lgi-2998-301250922.html
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Online Wig Store UNice Announces the Opening of its Membership System
- Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting
- Mirati Therapeutics Presents Preclinical Data on Novel Approach to PRMT5 Inhibition that Selectively Targets the PRMT5/MTA Complex in MTAP-Deleted Cancer Models